"4. Conclusion Based on the factors considered above, we do not consider that the value of the HML Unlisted Investments summarised in Section 3.1, and as used in the calculation of the historical monthly NTA for HML set out in the ASX Announcement for HML dated 8 June 2018, is unreasonable. "
- Forums
- ASX - By Stock
- HML
- Ann: Completion of NTA Review by independent expert
Ann: Completion of NTA Review by independent expert, page-7
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HML (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online